Gene Therapy for X-linked Myotubular Myopathy
Astellas Gene Therapies Inc. focuses on gene therapy approaches for X-linked Myotubular Myopathy (XLMTM), a severe neuromuscular disorder that affects muscle strength and respiratory function.
- XLMTM
- AT132
- Muscle weakness
- Neuromuscular disease
The research activity is centered on therapies intended to address the underlying genetic basis of the condition.
Respiratory Support in Neuromuscular Disease
The sponsor also studies treatment options for patients with ventilator dependence related to X-linked myotubular myopathy, with attention to respiratory involvement in advanced disease.
- Ventilator support
- Respiratory impairment
- Male patients
- Severe muscle disease
This area reflects a therapeutic interest in conditions where muscle weakness affects breathing and daily function.
Safety and Tolerability in Rare Disease Treatment
Clinical research includes evaluation of the safety and tolerability of investigational therapies for rare genetic disease, with emphasis on treatment suitability in a specialized patient population.
- Safety assessment
- Tolerability
- Rare disease
- Genetic disorder
The sponsor’s work in this area is closely tied to therapy development for inherited muscle disorders.
